Gross total resection rates in contemporary glioblastoma surgery: Results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brain mapping

Neurosurgery

Volumn 71, Issue 5, 2012, Pages 927-935

  Schucht, Philippe ^a   Beck, Jürgen ^a   Abu Isa, Janine ^a   Andereggen, Lukas ^a   Murek, Michael ^a   Seidel, Kathleen ^a   Stieglitz, Lennard ^a   Raabe, Andreas ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

5 ALA; Complete resection of the contrast enhancing tumor; Glioblastoma; Gross total resection; Intraoperative mapping; Neuronavigation

Indexed keywords

AMINOLEVULINIC ACID;

ADULT; AGED; BRAIN MAPPING; CANCER SURGERY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; FLUORESCENCE IMAGING; GLIOBLASTOMA; HEMIANOPIA; HEMIPARESIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SENSORY DYSFUNCTION;

ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; BRAIN MAPPING; BRAIN NEOPLASMS; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, MOTOR; FEMALE; GLIOBLASTOMA; HUMANS; INTRAOPERATIVE PERIOD; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; NEUROSURGICAL PROCEDURES; PHOTOSENSITIZING AGENTS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 84868204270     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e31826d1e6b     Document Type: Review

References (33)

1. Tait MJ, Petrik V, Loosemore A, Bell BA, Papadopoulos MC. Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases. Br J Neurosurg. 2007;21(5):496-500.
2. Stummer W, Reulen HJ, Meinel T, et al. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery. 2008;62(3):564-576.
3. Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95(2):190-198.
4. Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery. 2008;62(4):753-764.
5. Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS. An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg. 2011;115(1): 3-8.
6. Sawaya R, Hammoud M, Schoppa D, et al. Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery. 1998;42(5):1044-1055; discussion 1055-1056.
7. Cedzich C, Pechstein U, Schramm J, Schäfer S. Electrophysiological considerations regarding electrical stimulation of motor cortex and brain stem in humans. Neurosurgery. 1998;42(3):527-532.
8. Taniguchi M, Cedzich C, Schramm J. Modification of cortical stimulation for motor evoked potentials under general anesthesia: technical description. Neuro-surgery. 1993;32(2):219-226.
9. Szelényi A, Kothbauer KF, Deletis V. Transcranial electric stimulation for intraoperative motor evoked potential monitoring: stimulation parameters and electrode montages. Clin Neurophysiol. 2007;118(7):1586-1595.
10. Neuloh G, Pechstein U, Cedzich C, Schramm J. Motor evoked potential monitoring with supratentorial surgery. Neurosurgery. 2004;54(5):1061-1070.
11. Suess O, Kombos T, Hoell T, Baur S, Pietilae T, Brock M. A new cortical electrode for neuronavigation-guided intraoperative neurophysiological monitoring: technical note. Acta Neurochir (Wien). 2000;142(3):329-332.
12. Berger MS, Kincaid J, Ojemann GA, Lettich E. Brain mapping techniques to maximize resection, safety, and seizure control in children with brain tumors. Neurosurgery. 1989;25(5):786-792.
13. Berger MS, Rostomily RC. Low grade gliomas: functional mapping resection strategies, extent of resection, and outcome. J Neurooncol. 1997;34(1):85-101.
14. Duffau H, Capelle L, Denvil D, et al. The role of dominant premotor cortex in language: a study using intraoperative functional mapping in awake patients. Neuroimage. 2003;20(4):1903-1914.
15. Cedzich C, Taniguchi M, Schäfer S, Schramm J. Somatosensory evoked potential phase reversal and direct motor cortex stimulation during surgery in and around the central region. Neurosurgery. 1996;38(5):962-970.
16. Calancie B, Harris W, Brindle GF, Green BA, Landy HJ. Threshold-level repetitive transcranial electrical stimulation for intraoperative monitoring of central motor conduction. J Neurosurg. 2001;95(2 suppl):161-168.
17. Kuhnt D, Becker A, Ganslandt O, Bauer M, Buchfelder M, Nimsky C. Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance. Neuro Oncol. 2011;13(12):1339-1348.
18. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006;7 (5):392-401.
19. Vogelbaum MA, Jost S, Aghi MK, et al. Application of novel response/progression measures for surgically delivered therapies for glioma: Response Assessment in Neuro-Oncology (RANO) Working Group. Neurosurgery. 2012;70(1)234-243.
20. Feigl GC, Ritz R, Moraes M, et al. Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring. J Neurosurg. 2010;113(2):352-357.
21. Butowski N, Lamborn KR, Berger MS, Prados MD, Chang SM. Historical controls for phase II surgically based trials requiring gross total resection of glioblastoma multiforme. J Neurooncol. 2007;85(1):87-94.
22. Ramakrishna R, Barber J, Kennedy G, et al. Imaging features of invasion and preoperative and postoperative tumor burden in previously untreated glioblas-toma: correlation with survival. Surg Neurol Int. 2010;1:40.
23. Vuorinen V, Hinkka S, Färkkilä M, Jääskeläinen J. Debulking or biopsy of malignant glioma in elderly people: a randomised study. Acta Neurochir (Wien). 2003;145(1):5-10.
24. McGirt MJ, Mukherjee D, Chaichana KL, Than KD, Weingart JD, Quinones-Hinojosa A. Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme. Neurosurgery. 2009;65(3):463-469.
25. Hatiboglu MA, Weinberg JS, Suki D, et al. Impact of intraoperative high-field magnetic resonance imaging guidance on glioma surgery: a prospective volumetric analysis. Neurosurgery. 2009;64(6):1073-1081.
26. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyr-ins: a prospective study in 52 consecutive patients. J Neurosurg. 2000;93(6):1003-1013.
27. Nimsky C, Ganslandt O, Buchfelder M, Fahlbusch R. Intraoperative visualization for resection of gliomas: the role of functional neuronavigation and intraoperative 1.5 T MRI. Neurol Res. 2006;28(5):482-487.
28. Claus EB, Horlacher A, Hsu L, et al. Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer. 2005;103 (6):1227-1233.
29. Senft C, Bink A, Franz K, Vatter H, Gasser T, Seifert V. Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncol. 2011;12(11):997-1003.
30. Kuhnt D, Ganslandt O, Schlaffer SM, Buchfelder M, Nimsky C. Quantification of glioma removal by intraoperative high-field magnetic resonance imaging: an update. Neurosurgery. 2011;69(4):852-862.
31. Stummer W, Tonn JC, Mehdorn HM, et al. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article. J Neurosurg. 2011;114(3):613-623.
32. Chang EF, Clark A, Smith JS, et al. Functional mapping-guided resection of low-grade gliomas in eloquent areas of the brain: improvement of long-term survival: clinical article. J Neurosurg. 2011;114(3):566-573.
33. Chang SM, Parney IF, Huang W, et al. Patterns of care for adults with newly diagnosed malignant glioma. JAMA. 2005;293(5):557-564.